August 29, 2011
The first generic version of Levaquin tablets and solution were recently approved by the FDA.
Levaquin belongs to a class of antibiotics called fluoroquinolones and is used to treat infections, such as pneumonia and chronic bronchitis, as well as sinus, urinary tract, kidney, prostate, and skin infections. Similar products include Avelox® and Cipro®.
In 2010, Humana's net paid for Levaquin was approximately $29 million. Generic Levaquin will be placed in tier 1 for Commercial Rx3 plans and tier 2 for Commercial Rx4.
Humana will notify members about the release of the generic via SmartSummary®.